Home/Stacks/Sexual Health Stack
SEXUAL HEALTH STACK

Sexual Health Stack

PT-141 + Kisspeptin-10 — the central arousal + HPG-axis combination users research for libido and hormonal support.

Educational overview only — not medical advice. No compound in this stack is presented as a treatment for any condition. Any protocol decision is a conversation with your licensed healthcare provider.

About This Stack

The Sexual Health Stack pairs PT-141 (melanocortin receptor agonist, central arousal) with Kisspeptin-10 (HPG-axis upstream signal driving endogenous testosterone). The two operate on completely different axes: PT-141 acts centrally on arousal circuits, while Kisspeptin-10 restarts the pituitary-gonadal signaling cascade upstream of LH/FSH/testosterone.

Users research this combination in the context of libido concerns where standard testosterone labs are normal-to-low and central arousal + endogenous HPG support are both relevant. PT-141 is FDA-approved as Vyleesi for premenopausal HSDD. Kisspeptin-10 is research-only.

Neither is a treatment for sexual dysfunction without a licensed provider's workup. Many cases trace to non-hormonal drivers (SSRIs, relationship factors, vascular, sleep apnea) that respond to different interventions.

Why These Compounds Are Researched Together

PT-141 binds melanocortin receptors (primarily MC4R) centrally and drives sexual arousal through central circuits independent of sildenafil-class vasodilation. Kisspeptin-10 is the upstream HPG-axis signal — it stimulates GnRH release, which drives LH/FSH release, which drives gonadal testosterone production. The two compounds address different but overlapping aspects of the sexual-response system.

Compounds in the Sexual Health Stack

PT-141CENTRAL AROUSAL
PT-141 (Bremelanotide)
Melanocortin-receptor agonist — central sexual arousal circuit. FDA-approved as Vyleesi.
kisspeptin-10HPG AXIS
Upstream HPG-axis stimulator — drives endogenous LH/FSH/testosterone release.

Biomarkers Users Commonly Track

When running a stack like this, these biomarkers let users see how the compounds perform in context. Trended across draws, they reveal whether the stack is actually moving the markers it should — or producing unintended shifts that warrant a provider conversation.

HORMONE
Total Testosterone
Baseline hormone status — morning fasted draw.
HORMONE
Free Testosterone
Bioavailable fraction — often more informative than total.
HORMONE
LH
Pituitary signal — LH response is how you know HPG activation is working.
HORMONE
FSH
Pairs with LH for full pituitary-gonadal read.
HORMONE
Estradiol
Aromatization check — relevant whenever testosterone changes.
HORMONE
Prolactin
Elevated prolactin suppresses the axis and drives sexual dysfunction — rule out first.

Typical Cycle

PT-141 is typically as-needed. Kisspeptin-10 cycles vary widely in community reports. Both warrant provider oversight.

What to Discuss With Your Provider

Sexual-health complaints require a workup (complete hormone panel, SSRI history, sleep apnea screen, cardiovascular evaluation). A provider can identify the actual driver and whether peptide research is even the relevant direction.

Track the Sexual Health Stack against your labs.

Log every compound in the stack, upload your lab PDFs, and chart the biomarkers on this page across every draw. StackAI reads the panel in context of what you’re running.

Start tracking free →
Compliance notice: This page is informational and educational only. MyProtocolStack does not provide medical advice, diagnosis, or treatment. All references to compounds describe what users research and typically discuss with their clinician — not endorsements, prescriptions, or treatment recommendations. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision requires a licensed healthcare provider.